JURISDICTION : STATE ADMINISTRATIVE TRIBUNAL
ACT: HEALTH PRACTITIONER REGULATION NATIONAL LAW (WA) ACT 2010 (WA)
CITATION: PHARMACY BOARD OF AUSTRALIA and HAMILTON [2021] WASAT 138
MEMBER: JUDGE D R PARRY, DEPUTY PRESIDENT
MR J MANSVELD, SENIOR MEMBER
MS D PEARSON, SESSIONAL MEMBER
HEARD: 28 AND 29 JANUARY 2021, WRITTEN CLOSING SUBMISSIONS FILED 22 MARCH 2021, 7 MAY 2021 AND 18 MAY 2021, FURTHER ORAL SUBMISSIONS 20 JULY 2021 AND 10 AUGUST 2021, FURTHER WRITTEN SUBMISSIONS FILED 9 AUGUST 2021 AND 17 AUGUST 2021
DELIVERED : 20 OCTOBER 2021
FILE NO/S: VR 95 of 2017
BETWEEN: PHARMACY BOARD OF AUSTRALIA
Applicant
AND
FELECIA HAMILTON
Respondent
Catchwords:
Vocational regulation Registered health practitioners Pharmacists Conduct occurring prior to commencement of Health Practitioner Regulation National Law when practitioner registered as a pharmaceutical chemist under Pharmacy Act 1964 (WA) Proceeding commenced under Health Practitioner Regulation National Law after expiration of transitional provision providing that proceedings may be taken under Health Practitioner Regulation National Law in relation to a registered health practitioner's behaviour while registered under a corresponding prior Act as if person were registered under Health Practitioner Regulation National Law Whether Tribunal required to determine issue and characterisation of practitioner's conduct and issue of penalty in consequence of practitioner's conduct under Health Practitioner Regulation National Law or corresponding prior Act – Statutory interpretation – Whether proceeding can be commenced under expired transitional provision where applicant opened 'own-motion notification' in relation to practitioner's behaviour prior to expiration of transitional provision – Whether presumption against retrospective operation of statute rebutted Penalty Engaging in practice of dispensing anabolic androgenic steroids to patients for a purpose which practitioner knew did not accord with recognised therapeutic standards Engaging in practice of dispensing anabolic androgenic steroids to patients in quantities and/or combinations which practitioner knew had potential for misuse and abuse and which practitioner ought to have known, but did not know, were not necessary for any proper therapeutic purpose, were likely to constitute an unacceptable hazard to health of patients and/or others, and had potential for dependency Engaging in practice of dispensing anabolic androgenic steroids to patients by dispensing repeat authorisations and/or multiple prescriptions when practitioner knew there was potential for misuse and abuse and ought to have known, but did not know, that quantity and/or combination was likely to constitute unacceptable hazard to health of patients and/or others, and had potential for dependency Costs
Legislation:
Drugs, Poisons and Controlled Substances Act 1981 (Vic)
Health Practitioner Regulation National Law (WA) Act 2010 (WA), s 3, s 4, s 5, s 35, s 35(1)(i), s 139, s 193, s 193(1)(a)(i), s 193(2)(a)(i), s 196, s 305, s 305(3), Pt 8, Sch 7, cl 7, cl 12(1), cl 34(1)(b), cl 37
Health Practitioner Regulation National Law (WA) Regulations 2010 (WA), reg 30, reg 30(2), reg 30(3)
Health Professions Registration Act 2005 (Vic), s 77(1)
Interpretation Act 1984 (WA), s 37(1)(c), s 37(1)(f)
Legal Profession Act 2008 (WA), s 275
Medical Act
Keep reading for free
Create a free CaseChat account to read PHARMACY BOARD OF AUSTRALIA and HAMILTON and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] WASAT 138
- Decision Date
CaseChat Overview and Summary
The Tribunal concluded that it was necessary to assess Hamilton's conduct under the National Law. The Court found that the presumption against retrospective operation of statute was not rebutted, and the proceeding could not be commenced under the expired transitional provision. However, the Tribunal determined that the conduct in question, which involved dispensing anabolic androgenic steroids to patients for purposes that did not align with recognised therapeutic standards, in quantities and combinations that had the potential for misuse and abuse, and the dispensing of repeat authorisations and multiple prescriptions despite the known potential for misuse and abuse, constituted professional misconduct. The Tribunal found that Hamilton's conduct had the potential to cause an unacceptable hazard to the health of patients and others, and had the potential for dependency.
The Tribunal ordered that Hamilton's registration as a pharmacist be cancelled and declared that his conduct constituted professional misconduct. Additionally, the Tribunal ordered that Hamilton pay the costs of the proceeding. The decision highlights the importance of adhering to recognised therapeutic standards and the potential consequences of engaging in conduct that poses an unacceptable hazard to the health of patients and others.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Established by: MR J